Article
Genomic Alterations and Clinical Characterization in Chinese Patients with Metastatic Colorectal Cancer.
Discovery medicine - 1 Jul 2024
Zhang Xu-Hui, Zhou Jie-Qiong, Wei Qing, Li Jian, Xu Ting, Bai Chun-Mei, Zhou Jian-Feng, Wang Xi-Cheng
Abstract excerpt
BACKGROUND: Metastatic colorectal cancer (mCRC) is increasingly characterized by myriad genomic alterations beyond the well-known factors such as RAS, BRAF, and microsatellite instability (MSI). Novel genomic changes, including ERBB2 amplifications, mutations, and gene fusions, are now recognized as potential targets for precision therapy. This study aims to explore the genomic landscape of a Chinese cohort with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
